TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹14,505 Cr | ₹14,468 Cr | ₹12,606 Cr | ₹13,653 Cr | ₹13,577 Cr |
What is the latest Total Liabilities ratio of TORRENT PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹14,505 Cr |
Mar2023 | ₹14,468 Cr |
Mar2022 | ₹12,606 Cr |
Mar2021 | ₹13,653 Cr |
Mar2020 | ₹13,577 Cr |
How is Total Liabilities of TORRENT PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹14,505 Cr | 0.26 | |
Mar2023 | ₹14,468 Cr | 14.77 | |
Mar2022 | ₹12,606 Cr | -7.67 | |
Mar2021 | ₹13,653 Cr | 0.56 | |
Mar2020 | ₹13,577 Cr | - |
Compare Total Liabilities of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹108,604.4 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,306.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,343.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
CIPLA | ₹117,323.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
MANKIND PHARMA | ₹99,891.5 Cr | 0.6% | 5.7% | 6.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,941.5 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -0.3% |
9% |
22.3% |
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses